Services for the analysis of the effect of a test agent (chemical compound) on a rat model of inherited retinal degeneration

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES.  IAW FAR 6.302-1(a) - Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements - this purchase order is intended to be awarded as a sole source procurement to EyeCro the ophthalmic contract research services for the purchase of services for the analysis of the effect of a test agent (chemical compound) on a rat model of inherited retinal degeneration. Reports of these analyses will be used as a basis for assessing the suitability of these materials for use in biological activity studies, pharmacological studies, toxicological studies, and potentially clinical trials. Data provided in these analytical reports can further be supplied to the Food and Drug Administration (FDA) as part of the Investigational New Drug (IND) filings for new agents applicable for inherited retinal degeneration.

This notice of intent is not a request for competitive proposals.  However, all proposals received by the date specified herein will be considered by the Government. A determination by the Government not to compete with this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

Interested parties may identify their interest and may submit a quote and/or capability statement by 3:00 PM EST, 19 July 2022, which shall be considered by the Government. Capability statements and quotes shall be sent via email to holleyv@od.nih.gov.

Attachments:

1. J&A, EyeCro/Charlesson, LLP